Guardian REAL-Time
Continuous Glucose Monitoring System
Guardian REAL-Time Continuous Glucose Monitoring System

Guardian REAL-Time Continuous Glucose Monitoring System

The Guardian® REAL-Time System is a standalone continuous glucose monitor that offers users REAL-Time, around-the-clock information about glucose trends and patterns.

How It Works

The Guardian® REAL-Time continuous glucose monitoring system allows people with diabetes the ability to see their glucose patterns and tools that empower them to overcome their glucose excursions.

A wireless transmitter sends information from a glucose sensor to the Guardian Monitor for readings every 5 minutes, 24 hours a day, and provides helpful alerts for peace of mind around the clock.

REAL Insights With Glucose Sensors

  • Inserts under the skin in a virtually painless process
  • Measures current glucose levels every 5 minutes, 24 hours a day
  • Fingersticks are required to calibrate the glucose sensor and before making treatment decisions

REAL-Time Readings

  • 60% of lows may be missed by fingerstick testing1
  • Glucose readings on the Guardian updated every 5 minutes, 24 hours a day
  • Increases glycemic awareness and promotes proactive control1-3
Continuous Glucose Monitor vs fingerstick testing

Get far more useful information than just fingerstick testing alone with 24 hour glucose monitoring

REAL-Time Trend Information

  • Trend arrows show the direction and rate of glucose level changes, enabling preventive action
  • Enables users to address even brief fluctuations in glucose levels, which can impact the development of long-term diabetes complications, such as eye, nerve, kidney and heart disease4,5
  • Trend graphs reveal the effects of diet, exercise, insulin, and medication on glucose levels
  • Works with CareLink® software for online data management and retrospective analysis

REAL-Time Alarms

  • Sounding or vibrating alarms
  • Warn of low and high glucose levels that fingersticks or A1C testing alone may not reveal6
  • Predictive alerts warn 5 to 30 minutes before glucose leaves target area
  • Result in significant reduction in duration of hypoglycemic events6
Reduction in hypoglycemic events with continuous glucose monitor alerts

Patient response to REAL-Time Alarms resulted in 48% reduction in mean duration of hypoglycemic excursions (from 64.4 minutes to 33.6 minutes).6

REAL Innovations

  • Easy-to-use menu navigation
  • Millions of safety checks for safe, reliable use
  • Downloadable continuous glucose trend histories from the user's device onto a computer
  • MiniLink® is waterproof to a depth of 8 feet for up to 30 minutes when connected to the glucose sensor

REAL Comfort

  • Worn on belt, in pocket, or under clothing
  • Tiny and discreet
  • Easy and painless glucose sensor insertion

View the clinical benefits of continuous glucose monitoring.

Indications for Use

The Guardian REAL-Time Continuous Glucose Monitoring System is intended to continuously record interstitial glucose levels in persons 7 years of age or older who have Type 1 or Type 2 diabetes. This information is intended to supplement, not replace, blood glucose information obtained using standard home glucose monitoring devices. This information collected by The Guardian REAL-Time Continuous Glucose Monitoring System may be downloaded and displayed on a computer and reviewed by healthcare professionals. This information may allow indentification of patterns of glucose-level excursions above or below the desired range, facilitating therapy adjustments that may minimize these excursions. A version of the product specially designed for children is indicated for patients age 7-17.

Contraindications

Successful operation of The Guardian REAL-Time Continuous Glucose Monitoring System requires adequate vision and hearing. Use of The Guardian REAL-Time Continuous Glucose Monitoring System is not recommended for patients whose impaired vision or hearing does not allow full recognition of the monitor signals and alarms, or who do not have a caregiver that can perform this function for them.

Warnings/Precautions

The Guardian REAL-Time Continuous Glucose Monitoring System users should be educated to program and operate the monitor and respond to alarm conditions prior to attempted use of the system. The current and voltage signals shown in the monitor are to be used only for finding potential problems with The Guardian REAL-Time Continuous Glucose Monitoring System and do not indicate current glucose value. Infection and/or site irritation may result from improper insertion and maintenance of insertion site.

Safety Information

Patients should always discuss potential risks and benefits with a physician. Please review the product manual prior to use for detailed instructions and disclosure.

For complete safety information, including contraindications, warnings/complications, and potential complications, see product label or visit the Indications, Safety, and Warnings page.

References

  1. Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001;24(12):2030-2034.
  2. Bode BW, Gross TM, Thornton KR, et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res and Clin Pract. 1999;46:183- 190.
  3. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics. 2003;111(5 Pt 1):933- 938.
  4. Derr R, Garrett E, Stacy G, et al. Is HbA1C affected by glycemic instability? Diabetes Care. 2003;26(10):2728-2733.
  5. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA. 1997;277(5):374-375.
  6. Bode BW, Gross K, Rikalo N, et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous glucose monitoring system. Diabetes Technol Ther. 2004;6(2):105-113.
Last updated: 24 Jan 2012